MedPath

The effect of exercise and royal jelly on liver enzymes in multiple sclerosis patients

Phase 3
Conditions
Multiple sclerosis.
Multiple sclerosis
Registration Number
IRCT20180612040073N3
Lead Sponsor
niversity of Sistan and Baluchestan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Multiple sclerosis patients: Expanded Disability Status Scale (EDSS) between 0-4

Exclusion Criteria

Use of pharmaceutical supplements
With cardiovascular disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Aspartate Transaminase changes. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: Blood Sampling.;Alanine Aminotransferase Changes. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: Blood Sampling.;Alkaline Phosphatase Changes. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: Blood Samling.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath